APTOSE BIOSCIENCES INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.7 CAD | +4.94% |
|
+0.59% | -49.25% |
Chart calendar Aptose Biosciences Inc.
8edab1fac72b3a246463317df03b5ee3._7X-aZlURulSHLlukOIQxV8a4rEf65-yR6qZnoKPA6E.qdCXOcMWcKY0Ttsmz7NFkC8ouO5Xh93dfuDq6e_XdMqv6oo47TAo0RlI9A~aaf11959d254a7ab98c1bf3f6c73d13a
Upcoming events on Aptose Biosciences Inc.
Past events on Aptose Biosciences Inc.
| 2024-03-26 05:00 pm | Q4 2023 Earnings Call |
| 2024-03-26 04:01 pm | Q4 2023 Earnings Release |
| 2023-12-09 06:15 pm | American Society of Hematology Meeting |
| 2023-11-09 05:00 pm | Q3 2023 Earnings Call |
| 2023-11-09 04:00 pm | Q3 2023 Earnings Release |
| 2023-10-30 08:30 am | European School of Haematology International Conference |
| 2023-10-28 | European School of Haematology International Conference |
| 2023-09-27 09:10 am | Cantor Global Healthcare Conference - Panel |
| 2023-09-11 02:00 pm | H.C. Wainwright Global Investment Conference |
| 2023-08-10 05:00 pm | Q2 2023 Earnings Call |
| 2023-08-10 04:02 pm | Q2 2023 Earnings Release After hours |
| 2023-06-10 12:00 pm | European Hematology Association Hybrid Congress - Abstract: PB1766 |
| 2023-06-05 | Reverse Split: 1 of 15 |
| 2023-05-23 12:00 pm | Annual General Meeting |
| 2023-05-17 08:00 am | RBC Capital Markets Global Healthcare Conference |
| 2023-05-08 05:00 pm | Q1 2023 Earnings Call |
| 2023-05-08 04:01 pm | Q1 2023 Earnings Release |
| 2023-04-20 02:00 pm | Canaccord Genuity Horizons in Oncology Virtual Conference - Panel |
| 2023-04-05 12:00 pm | Cantor The Future of Oncology Symposium |
| 2023-03-23 05:00 pm | Q4 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million CAD | Released Forecast Spread | -36,8 -36,1 -1.89% | -69,8 -69,8 -0.04% | -82,3 -71,1 -15.72% | -58,0 -58,8 1.26% | -70,9 -71,5 0.76% | -83,7 |
|
EBIT Million CAD | Released Forecast Spread | -37,0 -36,2 -2.13% | -70,0 -72,0 2.79% | -82,5 -73,1 -12.77% | -58,2 -57,7 -0.84% | -71,1 -72,3 1.67% | -75,6 |
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -36,2 -35,8 -1.21% | -69,3 -71,2 2.68% | -82,4 -72,9 -13.06% | -57,1 -57,0 -0.18% | -69,5 -70,7 1.7% | -74,9 |
|
Net income Million CAD | Released Forecast Spread | -36,2 -35,4 -2.17% | -69,3 -71,2 2.68% | -82,4 -72,9 -13.06% | -57,1 -57,0 -0.17% | -69,5 -70,7 1.7% | -74,9 |
|
EPS CAD | Released Forecast Spread | -10,7 -10,1 -6.5% | -12,6 -13,2 4.47% | -13,8 -12,2 -12.99% | -9,22 -9,21 -0.09% | -10,3 -10,8 4.79% | -6,97 |
| Announcement Date | 10/03/20 | 23/03/21 | 22/03/22 | 23/03/23 | 26/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million CAD | Released Forecast Spread | -30,6 -18,6 -64.86% | -14,9 -21,4 30.48% | -13,7 -16,5 17.06% | -13,7 -15,0 9.23% | -14,2 -14,8 3.99% | -18,8 -17,1 -10.04% | -19,3 -19,3 -0.06% | -16,0 -20,2 20.55% | -16,4 -16,9 2.48% | -18,2 | -20,4 | -21,4 | -25,1 | |
|
EBIT Million CAD | Released Forecast Spread | -30,7 -20,2 -52.03% | -14,9 -16,3 8.21% | -13,7 -15,3 10.61% | -13,7 -14,5 5.77% | -14,2 -14,2 -0.27% | -18,8 -14,7 -27.7% | -19,4 -17,5 -10.95% | -16,1 -20,1 19.98% | -16,5 -18,4 10.71% | -14,3 | -12,6 | -13,9 | -14,9 | -14,9 |
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -30,7 -19,6 -56.38% | -14,9 -17,0 12.25% | -13,6 -15,5 12.55% | -13,4 -14,6 8.76% | -13,7 -14,0 2.4% | -18,3 -14,8 -23.08% | -18,9 -17,5 -8.37% | -15,8 -19,8 20.52% | -16,2 -17,6 8.03% | -15,9 | -16,3 | -17,5 | -19,9 | -15,1 |
|
Net income Million CAD | Released Forecast Spread | -30,7 -19,6 -56.38% | -14,9 -17,0 12.25% | -13,6 -15,5 12.55% | -13,4 -14,6 8.26% | -13,7 -14,0 2.4% | -18,3 -14,8 -23.08% | -18,9 -17,5 -8.37% | -15,8 -19,8 20.52% | -16,2 -17,6 8.03% | -15,9 | -16,3 | -17,5 | -19,9 | -15,1 |
|
EPS CAD | Released Forecast Spread | -5,10 -3,20 -59.52% | -2,34 -2,79 16.08% | -2,12 -2,54 16.34% | -2,25 -2,34 3.8% | -2,25 -2,21 -2.1% | -3,01 -2,40 -25.48% | -3,04 -2,58 -18.01% | -2,42 -2,75 11.86% | -1,95 -2,41 18.85% | -1,11 | -1,04 | -1,10 | -1,24 | -0,94 |
| Announcement Date | 22/03/22 | 09/05/22 | 02/08/22 | 01/11/22 | 23/03/23 | 08/05/23 | 10/08/23 | 09/11/23 | 26/03/24 | - | - | - | - | - |
More events
Past sector events for Aptose Biosciences Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- APS Stock
- Calendar Aptose Biosciences Inc.
